HIV-1 protease inhibitors with picomolar potency against pi-resistant HIV-1 by modification of the P₁' substituentDUFFY, Joseph L; KIRK, Brian A; LIN, Jiunn H et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 19, pp 3323-3326, issn 0960-894X, 4 p.Article

Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A proteaseRUDD, Michael T; MCCAULEY, John A; WAN, Bang-Lin et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 23, pp 7201-7206, issn 0960-894X, 6 p.Article

MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A ProteaseLIVERTON, Nigel J; CARROLL, Steven S; OLSEN, David B et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 1, pp 305-311, issn 0066-4804, 7 p.Article

The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strainsZHANG, Fengqi; CHAPMAN, Kevin T; TATA, James R et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 15, pp 2573-2576, issn 0960-894X, 4 p.Article

Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virusRAGHAVAN, Subharekha; ZHIJIAN LU; TATA, James R et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 19, pp 5432-5436, issn 0960-894X, 5 p.Article

P1' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1KIM, Ronald M; ROUSE, Elizabeth A; CHAPMAN, Kevin T et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 18, pp 4651-4654, issn 0960-894X, 4 p.Article

HIV protease inhibitors with picomolar potency against PI-resistant HIV-1 by extension of the P₃ substituentDULLY, Joseph L; RANO, Thomas A; LIN, Jiunn H et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 15, pp 2569-2572, issn 0960-894X, 4 p.Article

Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2―P4 linkersRUDD, Michael T; MCINTYRE, Charles J; WAN, Bang-Lin et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 23, pp 7207-7213, issn 0960-894X, 7 p.Article

Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: Coadministration with indinavirKEVIN, Nancy J; DUFFY, Joseph L; LIN, Jiunn H et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 22, pp 4027-4030, issn 0960-894X, 4 p.Article

A combinatorial library of indinavir analogues and its in vitro and in vivo studiesYUAN CHENG; RANO, Thomas A; LIN, Jiunn H et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 4, pp 529-532, issn 0960-894XArticle

Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYUAN CHENG; FENGQI ZHANG; LIXIA JIN et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 17, pp 2419-2422, issn 0960-894XArticle

Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replicationPRAKASH, Thazha P; PRHAVC, Marija; HILLIARD, Catherine et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 4, pp 1199-1210, issn 0022-2623, 12 p.Article

Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virusZHIJIAN LU; RAGHAVAN, Subharekha; GABRYELSKI, Lori et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 10, pp 1821-1824, issn 0960-894X, 4 p.Article

Identification of MK-944a: A second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitorsDORSEY, Bruce D; MCDONOUGH, Colleen; OLSEN, David B et al.Journal of medicinal chemistry (Print). 2000, Vol 43, Num 18, pp 3386-3399, issn 0022-2623Article